LAMBDA-CAP
LIVE

Serial Number

79250615

Owner

Numab Therapeutics AG

Attorney

Dennis S. Prahl

Filing Date

Dec 3, 2018

Add to watchlist:

No watchlists yet
View on USPTO

LAMBDA-CAP Trademark

Serial Number: 79250615 • Registration: 5980170

LAMBDA-CAP is a trademark filed by Numab Therapeutics AG on December 3, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Numab Therapeutics AG (2 trademarks)

Einsiedlerstrasse 34

Entity Type: 25

Trademark Details

Filing Date

December 3, 2018

Registration Date

February 11, 2020

Published for Opposition

November 26, 2019

Goods & Services

Research and development in the field of pharmaceutical products, biotechnology, antibodies and antibody fragments, proteins, micro-organisms and cells for therapeutic purposes; research with respect to pharmaceutical products, biotechnology, therapy, antibody and gene therapy; research, product development and quality control in the field of pharmacy, diagnostics and therapy; research in the field of chemistry and biology; industrial analysis and research services in the field of biochemistry and pharmaceuticals; research and development of antibody products for therapeutic purposes; preparing and conducting chemical, biochemical and biotechnological analysis and research

Pharmaceutical and veterinary products, namely, pharmaceutical products for the prevention and treatment of immune system related diseases and disorders, therapeutic vaccines; pharmaceutical preparations, namely, pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases; medicines for human medicine, namely, medicinal preparations for the treatment of infectious diseases and for use in oncology; chemical pharmaceutical products for the diagnosis and treatment of cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases; diagnostic preparations for medical use; chemical preparations for pharmaceutical use namely, for diagnosing and treating cancer, leukemia, lymphomas, inflammatory diseases, immunological diseases

Chemical, biochemical, biological and biotechnological products intended for industry and science, namely, biological preparations for use in industry and science, diagnostic preparations for clinical and medical laboratory use; chemical, biochemical, biological and biotechnological products, namely, antibodies and antibody particles for development and manufacture of pharmaceutical products; biological products, namely, antibodies and antibody fragments for use in laboratories, diagnosis and analysis for scientific and research purposes; chemical and biochemical additives, supports and substances for the manufacture of pharmaceutical products

Filing History

CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 1, 2026 APRE
TEAS SECTION 71 & 15 RECEIVED
Feb 5, 2026 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 11, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Dec 31, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 27, 2021 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 20, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 12, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 27, 2020 FICS
FINAL DISPOSITION PROCESSED
May 27, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 11, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 11, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 6, 2019 NONP
ASSIGNED TO LIE
Oct 21, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 16, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 10, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 10, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 10, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 10, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2019 TROA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 21, 2019 ADCH
REFUSAL PROCESSED BY IB
Apr 5, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 20, 2019 RFCS
REFUSAL PROCESSED BY MPU
Mar 20, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 13, 2019 RFCR
NON-FINAL ACTION WRITTEN
Mar 12, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 9, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 5, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 31, 2019 REPR